Gastrointestinal Hemorrhage: Clinical Trials

46 trials for Gastrointestinal Hemorrhage, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

26 completed, 7 unknown, 5 terminated, 4 recruiting. 46 Phase 3, 7 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 346Completed 26, Unknown 7, Terminated 5, Recruiting 4, Not yet recruiting 3, Withdrawn 1
Phase 27Completed 3, Not yet recruiting 1, Recruiting 1, Terminated 1, Unknown 1

Follow Gastrointestinal Hemorrhage: new trials by email Literature Review of Gastrointestinal Hemorrhage trials Research Report on Gastrointestinal Hemorrhage

Trials (filtered) newest first · largest first

All 46 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Chlorophyllin or Placebo With Standard Treatment for Late Radiation Induced Luminal Gastrointestinal Tract Bleeding
Chlorophyllin, Sodium Copper Complex, Placebo - Radiation Proctitis, Gastrointestinal Hemorrhage
Phase 3Not yet recruitingTata Memorial Centre2002026-09-152026-09-23
Trimebutine Maleate for Enhancing Gastric Visualization in Acute Upper Gastrointestinal Bleeding
Trimebutine Maleate, Placebo - Acute Upper Gastrointestinal Bleeding, Upper Gastrointestinal Bleeding
Phase 2 / Phase 3Not yet recruitingAssiut University1002026-09-012026-08-06
Routine Use of Potassium Competitive Acid Blocker vs. Guideline-Directed Gastrointestinal Protection Strategy in Acute Myocardial Infarction
Zastaprazan, Proton Pump Inhibitors (PPI) - Acute Myocardial Infarction (AMI), Gastrointestinal Bleeding
Phase 3RecruitingSamsung Medical Center50002026-06-232026-06-26
Tegoprazan for Prevention of Gastrointestinal Complication in Ischemic Stroke Patients on Antiplatelet Therapy (TegoStroke)
Tegoprazan 50 mg, Placebo - Ischemic Stroke, Ischemic Stroke, Acute
Phase 3RecruitingHanyang University Guri Hospital15242026-01-262026-07-08
Optimization Strategies for Blood Transfusion Protocols in the Emergency Treatment of Hemorrhagic Shock
low-titer O-group whole blood, 1:1:1 component transfusion, ABO- and Rh-compatible whole blood - Hemorrhage, Hemorrhagic Shock
Phase 3Not yet recruitingXijing Hospital1802025-09-012025-08-19
Reducing Gastrointestinal Bleeding With Proton Pump Inhibitor Therapy in Acute Venous Thromboembolism
Omeprazole 20 mg Oral Tablet, Placebo - Venous Thromboembolism, Gastro Intestinal Bleeding
Phase 3RecruitingOttawa Hospital Research Institute3602024-11-062026-07-22
Usefulness of Metoclopramide to Improve Endoscopic Visualization in Upper Gastrointestinal Bleeding
Metoclopramide, Placebo - Upper Gastrointestinal Bleeding
Phase 3CompletedUniversidad Autonoma de Nuevo Leon502023-03-012024-10-09
Bowel Preparation Regimen for Colon Capsule Endoscopy Procedure
polyethylene glycol, sodium phosphate, polyethylene glycol + ascorbic acid - Colon Cancer, Inflammatory Bowel Diseases
Phase 3CompletedRegion Skane1472023-02-012024-02-28
Faecal Microbiota Transplantation for Liver Cirrhosis
Faecal microbiota transplantation, Placebo - Liver Cirrhosis
Phase 2 / Phase 3RecruitingUniversity of Aarhus2202021-07-012025-01-24
Diltiazem Ointment With Lidocaine vs. Nifedipine Ointment With Lidocaine Ointment for Treatment of Chronic Anal Fissure
2% Diltiazem ointment with 1.5% lidocaine, 0.3% Nifedipine ointment with 1.5% lidocaine - Fissure in Ano, Rectal Diseases
Phase 2 / Phase 3UnknownUniversity of Calgary4302021-06-012021-05-14
Efficacy of Tranexamic Acid in Upper Gastrointestinal Bleeding
Tranexamic acid, Standard of care - Gastro Intestinal Bleeding
Phase 3UnknownPost Graduate Institute of Medical Education and Research, Chandigarh1602020-11-012021-03-09
Topical Vitamin E Ovules for the Treatment of Hemorrhoids
Vitamin E ovules, Prednisolone ointment - Bleeding Anal, Pain
Phase 3UnknownHospital General Universitario Elche1202020-05-012020-04-24
Re-EValuating the Inhibition of Stress Erosions (REVISE) Trial
Placebo (0.9% saline), Pantoprazole - Gastrointestinal Hemorrhage (Clinically Important, Upper)
Phase 3CompletedMcMaster University48002018-07-092024-09-20
Pediatric Intensive Care Ulcer Prophylaxis Pilot Trial
Pantoprazole, Placebo (for pantoprazole) - Gastrointestinal Hemorrhage
Phase 3CompletedMcMaster University1162017-01-092020-09-02
Prevention of Hemorrhage After Implantation of Mechanical Circulatory Support
Prophylactic treatment with Wilfactin - Heart Failure
Phase 3TerminatedUniversity Hospital, Lille312016-01-202019-07-11
Efficacy of Octreotide on Blood and Iron Requirements in Patients With Anemia Due to Angiodysplasias
Octreotide - Angiodysplasia, Vascular Malformations
Phase 3CompletedRadboud University Medical Center622015-09-012023-05-24
Ilaprazole for the Treatment and Prevention of Peptic Ulcer Bleeding in Chinese Patients
Ilaprazole, Omeprazole, Ilaprazole tablet - Peptic Ulcer Hemorrhage
Phase 3CompletedLivzon Pharmaceutical Group Inc.5402014-10-012017-12-06
Stress Ulcer Prophylaxis of Intravenous Esomeprazole in Chinese Seriously Ill Patients
Esomeprazole, Cimetidine - Stress Ulcer Prophylaxis
Phase 3CompletedAstraZeneca3432014-07-012017-03-10
Haemorrhage Alleviation With Tranexamic Acid- Intestinal System
Tranexamic Acid, Placebo - Gastrointestinal Bleeding
Phase 3CompletedLondon School of Hygiene and Tropical Medicine120092013-07-012020-04-17
High Dose Esomeprazole Na for Prevention of Rebleeding After Successful Endoscopic Therapy of a Bleeding Peptic Ulcer
Esomeprazole Na, Cimetidine, Esomeprazole Mg - Bleeding Peptic Ulcer
Phase 3CompletedAstraZeneca2392013-02-012016-03-08

Showing 20 of 46. Sign in to see all of them.

Narrower conditions

Peptic Ulcer Hemorrhage (6)  ·  Hematemesis (4)  ·  Hemorrhage (4)  ·  Fibrosis (3)  ·  Anemia (2)  ·  Cerebrovascular Disorders (2)  ·  Colonic Neoplasms (2)  ·  Hypertension, Portal (2)  ·  Inflammatory Bowel Diseases (2)  ·  Liver Diseases (2)  ·  Melena (2)  ·  Peptic Ulcer (2)  ·  Acute Coronary Syndrome (1)  ·  Anemia, Refractory (1)

Broader conditions

Digestive System Diseases (46)  ·  Gastrointestinal Diseases (46)  ·  Pathologic Processes (46)  ·  Pathological Conditions, Signs and Symptoms (46)  ·  Hemorrhage (42)  ·  Cardiovascular Diseases (6)  ·  Intestinal Diseases (6)  ·  Signs and Symptoms (6)  ·  Signs and Symptoms, Digestive (5)  ·  Vascular Diseases (5)  ·  Gastroenteritis (4)  ·  Hematologic Diseases (4)  ·  Hemic and Lymphatic Diseases (4)  ·  Vomiting (4)

Interventions

Omeprazole (4)  ·  Pantoprazole (4)  ·  Esomeprazole (3)  ·  Cimetidine (2)  ·  Gastric Lavage (2)  ·  Metoclopramide (2)  ·  Polyethylene Glycols (2)  ·  Tranexamic Acid (2)  ·  Amoxicillin (1)  ·  Ascorbic Acid (1)  ·  Aspirin (1)  ·  Capsule Endoscopy (1)  ·  Clarithromycin (1)  ·  Clopidogrel (1)  ·  Diatrizoate Meglumine (1)

Sponsors

AstraZeneca (4)  ·  Chinese University of Hong Kong (4)  ·  McMaster University (2)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Assiut University (1)  ·  Bausch Health Americas, Inc. (1)  ·  Casa Sollievo della Sofferenza IRCCS (1)  ·  Centre Hospitalier Universitaire, Amiens (1)  ·  Cogentus Pharmaceuticals (1)  ·  Dr Vipul Jairath (1)  ·  Hanyang University Guri Hospital (1)  ·  Hospital Clinic of Barcelona (1)  ·  Hospital General Universitario Elche (1)  ·  Hospital Universitari Vall d'Hebron Research Institute (1)  ·  Hospital Universitari de Bellvitge (1)

Countries

China (8)  ·  France (7)  ·  Canada (6)  ·  United Kingdom (5)  ·  United States (5)  ·  Spain (4)  ·  Germany (3)  ·  South Korea (3)  ·  Australia (2)  ·  Denmark (2)  ·  Hong Kong (2)  ·  India (2)  ·  Italy (2)  ·  Mexico (2)  ·  Netherlands (2)

Top investigators

Tore Lind, MD (2)  ·  Andriulli Angelo, MD (1)  ·  Antonio Soriano, M D, Ph D (1)  ·  Cheol Min Shin, MD (1)  ·  Christopher Fraser, MB BCH, MD, FRCP (1)  ·  Deborah Cook, MD (1)  ·  Deborah Siegal, MD (1)  ·  Ervin Toth, MD PhD (1)  ·  Francis KL Chan, MD (1)  ·  Haleema Shakur-Still (1)  ·  Henry KM Joeng, MBBS (1)

Results publications

PMID 19086953, PMID 19221370, PMID 20151726, PMID 20925534, PMID 21181319, PMID 25245464, PMID 25409738, PMID 25432532, PMID 25926146, PMID 25956718, PMID 26581750, PMID 27012778, PMID 27619827, PMID 27641510, PMID 28070941, PMID 28533916, PMID 29638148, PMID 29720248, PMID 31362765, PMID 32563378, PMID 34663491, PMID 35041627, PMID 37644556, PMID 37968012, PMID 38057875, PMID 38158089, PMID 38706390, PMID 38875111, PMID 39938959, PMID 40379131, PMID 41213683, PMID 42186360, PMID 42674788

NIH funding

2009 (1), 2015 (1)